Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
about
Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratificationNew serological markers in inflammatory bowel disease are associated with complicated disease behaviourAnti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel diseaseAnti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsIntestinal microbiota transplant - current state of knowledgeAntibody markers in the diagnosis of inflammatory bowel diseasePrimary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectiveEvaluation of inflammatory activity in Crohn's disease and ulcerative colitisNovel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodiesDiagnosis of inflammatory bowel disease: Potential role of molecular biometrics.Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBDUpdate on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a mulAnti-Saccharomyces cerevisiae antibodies in coeliac diseaseGut mucosal response to food antigens in Crohn's disease.Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitisFungi and inflammatory bowel diseases: Alterations of composition and diversity.The utility of ANCA and ASCA in inflammatory bowel disease.Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patientsSerological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.The development of animal models of inflammatory bowel disease.Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasisIsolation and characterization of a novel short peptide associated with Crohn's disease.Specificity and prevalence of natural bovine antimannan antibodies.Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.The role of bacteria in the pathogenesis of inflammatory bowel diseaseMolecular cloning reveals nearly half of patients with Crohn's disease have an antibody to peroxiredoxin 6-like protein.Indeterminate colitisBlockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot studyMycobiota in gastrointestinal diseases.The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn's diseaseSerum anti-Saccharomyces cerevisiae antibodies in Greek patients with Behcet's disease.Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.
P2860
Q22241487-F553C39C-F15C-433E-AE35-0043F600E925Q22242048-2BB4F622-290C-49C7-ADBE-E55CC001D8F7Q22242053-72B96383-DA52-47BF-A0D0-5E6DAFC75F11Q24684357-11DC0B4E-8E1F-4CC5-963D-8607C9E26EB7Q26741017-03FB39F8-EC1D-4FBB-8857-6B7C99AF1309Q26774452-9E7A6966-662C-42EB-8BB4-E526509BAF46Q26781780-E64D5655-D86C-4B0C-850D-F25CBD7FC322Q26996550-AF7F394C-F697-418A-83A9-C79EFD44BE3AQ27000411-0BD38DFC-D8F3-4C0D-AA5A-8D4197E48495Q27691430-86890BAE-EA92-4FAC-9F09-FA09FA8C1834Q28297789-62E1C1DC-16F3-455C-9225-934241954C3EQ28303013-E0324E73-E820-407A-96AE-AF29168D5FE3Q28305627-C8E92E37-27D5-4C90-B06E-99AD65A17EF6Q30717067-4A5D9D23-04DE-4B88-A307-B868397D09E5Q30885917-D3D71BDB-A32F-411D-B22D-D153CCEE0A56Q30895822-83D50BEC-0F48-4E30-92FF-80FF7BED998BQ33347197-B944B030-46E7-4871-81DC-5D26EA131C66Q33535518-D63F301F-9574-40B5-AD81-7AC294C3DD34Q33640438-723F6F88-8946-4C24-8865-6F2162F93024Q33715448-895A487A-7C0D-48E3-91ED-629556ED0DC0Q33761406-050BABAB-C7AB-4966-B10A-EBA726C1AA49Q33867175-BD992CCF-B4CF-4B10-8ACE-FF84B13177DDQ33894195-376628F6-8001-482B-A449-068E04802510Q33916303-EDDB63EF-3647-4475-B4E4-C8714A129E7EQ33960316-D7C5C06B-E6DD-425A-9B37-2BC36FEDB181Q33974071-CDD14FBF-0D4D-4DA2-8851-3A1B574FA136Q33998047-F0F9240E-990E-4834-82FC-078D94D12AE3Q34143593-A84A781E-6E71-4AC4-AEDC-7768A6DD1AF7Q34152338-05FAD870-BCAA-46B3-86FE-3D654C9BD6C6Q34206639-7FCF03D7-562A-46CA-AA13-5DDC9CCA90C0Q34230939-FEABD910-C129-43BA-8637-D4F900A9177EQ34371161-69D9C4FF-9C4D-4ACE-8A37-933913F6F750Q34395229-6FE74ABC-706E-46F5-B2F5-6621EA027CA0Q34413367-2FAF5F7D-818F-462A-96CB-CA514204F67CQ34447163-A1B17A7D-AA48-4DD3-AE5E-2376C2AA9C0BQ34626609-7915FE33-C3F0-4FCC-84B3-2BD6FB28583FQ34635487-C7C9A727-849B-4AB3-9337-9557D74EA337Q34720198-69D3B1E5-ABF8-4240-BFEC-0078EA76ADEFQ34726793-82844ECA-28CE-441D-97A3-92E122DD7958Q34962856-86A8BEDA-AEAA-4F89-A539-11891F680299
P2860
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@ast
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@en
type
label
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@ast
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@en
prefLabel
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@ast
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@en
P2093
P2860
P921
P356
P1433
P1476
Anti-Saccharomyces cerevisiae ...... revalence and diagnostic role.
@en
P2093
Charrier G
Colombel JF
Duthilleul P
Grandbastien B
Quinton JF
P2860
P304
P356
10.1136/GUT.42.6.788
P407
P577
1998-06-01T00:00:00Z